← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2004Last known activity
Nov 1, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 4 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Recent trials (6)
- NCT05744583Lead sponsorN/ANov 1, 2022
- NCT05744583Overall official - principal investigatorN/ANov 1, 2022
- NCT05744583Reponsible party - principal investigatorN/ANov 1, 2022
- NCT04730401CollaboratorPhase 2Jan 27, 2021
- NCT01638416CollaboratorPhase 3Oct 31, 2012
- NCT01119690CollaboratorN/ASep 1, 2004
Details
- Last known activity
- Nov 1, 2022